![DSpace logo](/jspui/image/logo.gif)
Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13531
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gaikwad, Anil Bhanudas | - |
dc.date.accessioned | 2023-12-27T07:05:56Z | - |
dc.date.available | 2023-12-27T07:05:56Z | - |
dc.date.issued | 2023 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/abs/pii/B9780128239315000165 | - |
dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13531 | - |
dc.description.abstract | Acute kidney injury (AKI) appears as a serious public health issue that remains associated with higher rates of morbidity and mortality. A lot of research has been carried out to understand the complex pathogenesis of AKI, but only supportive therapies are available. Growing evidence has demonstrated the vital role of epigenetic regulation in gene expression under the pathogenesis of AKI. In this chapter, we discuss the current advances in the epigenetic regulation of AKI and offer mechanistic insight into the role of histone modifications such as acetylation, methylation, phosphorylation, and crotonylation in the pathological development of AKI. Moreover, this chapter emphasizes histone modifications as a putative therapeutic target for the treatment of AKI. In the future, rigorous investigation of epigenetics is needed to provide a better understanding of the pathophysiology of AKI, thereby giving newer insight into the treatment of AKI. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | Acute Kidney Injury (AKI) | en_US |
dc.subject | Histone acetylation | en_US |
dc.title | Role of histone modifications in the development of acute kidney injury | en_US |
dc.type | Article | en_US |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.